{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:49:32Z","timestamp":1792464572506,"version":"4.5.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.13249","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T04:29:56Z","timestamp":1597379396000},"page":"e2013249","source":"Crossref","is-referenced-by-count":39,"title":["Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder"],"prefix":"10.1001","volume":"3","author":[{"given":"Gerd","family":"Kvale","sequence":"first","affiliation":[{"name":"Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway"},{"name":"Department of Clinical Psychology, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne","family":"Hansen","sequence":"additional","affiliation":[{"name":"Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway"},{"name":"Center for Crisis Psychology, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Hagen","sequence":"additional","affiliation":[{"name":"Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway"},{"name":"Department of Psychiatry, Molde Hospital, Molde, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Abramowitz","sequence":"additional","affiliation":[{"name":"Department of Psychology and Neuroscience, University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore","family":"B\u00f8rtveit","sequence":"additional","affiliation":[{"name":"Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle G.","family":"Craske","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E.","family":"Franklin","sequence":"additional","affiliation":[{"name":"Rogers Memorial Hospital, Oconomowoc, Wisconsin"},{"name":"Department of Psychology, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein","family":"Haseth","sequence":"additional","affiliation":[{"name":"Nidaros Outpatient Psychiatric Unit, St. Olavs Hospital, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Himle","sequence":"additional","affiliation":[{"name":"School of Social Work, Department of Psychiatry, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurd","family":"Hystad","sequence":"additional","affiliation":[{"name":"Department for Psychosocial Science, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unn Beate","family":"Kristensen","sequence":"additional","affiliation":[{"name":"Gaustad Hospital, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunvor","family":"Launes","sequence":"additional","affiliation":[{"name":"Solvang Outpatient Psychiatric Unit, S\u00f8rlandet Hospital, Kristiansand, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Lund","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, Haukeland University Hospital, Bergen, Norway"},{"name":"Department of Clinical Medicine, Section for Psychiatry, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stian","family":"Solem","sequence":"additional","affiliation":[{"name":"Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway"},{"name":"Department of Psychology, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-G\u00f6ran","family":"\u00d6st","sequence":"additional","affiliation":[{"name":"Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway"},{"name":"Department of Psychology, Stockholm University, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"issue":"6","key":"zoi200503r1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"zoi200503r2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1001\/archpsyc.1988.01800360042006","article-title":"The epidemiology of obsessive-compulsive disorder in five US communities.","volume":"45","author":"Karno","year":"1988","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"zoi200503r3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1017\/S0033291713000470","article-title":"Age of onset in obsessive-compulsive disorder: admixture analysis with a large sample.","volume":"44","author":"Anholt","year":"2014","journal-title":"Psychol Med"},{"key":"zoi200503r4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cpr.2015.06.003","article-title":"Cognitive behavioral treatments of obsessive-compulsive disorder: a systematic review and meta-analysis of studies published 1993-2014.","volume":"40","author":"\u00d6st","year":"2015","journal-title":"Clin Psychol Rev"},{"issue":"8","key":"zoi200503r5","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","article-title":"Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis.","volume":"3","author":"Skapinakis","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"zoi200503r6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0304-3940(89)90379-0","article-title":"D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics.","volume":"98","author":"Hood","year":"1989","journal-title":"Neurosci Lett"},{"issue":"2","key":"zoi200503r7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0028-3908(01)00073-9","article-title":"Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine.","volume":"41","author":"Sheinin","year":"2001","journal-title":"Neuropharmacology"},{"issue":"8","key":"zoi200503r8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.biopsych.2006.12.020","article-title":"D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.","volume":"62","author":"Kushner","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"3","key":"zoi200503r9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1176\/appi.ajp.2007.07050776","article-title":"Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.","volume":"165","author":"Wilhelm","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"5","key":"zoi200503r10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/jamapsychiatry.2016.3955","article-title":"D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: a systematic review and meta-analysis of individual participant data.","volume":"74","author":"Mataix-Cols","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"zoi200503r11","first-page":"2101","article-title":"D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.","volume":"9","author":"Xia","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"zoi200503r12","article-title":"Augmentation of cognitive and behavioural therapies (CBT) with D-cycloserine for anxiety and related disorders.","author":"Ori","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"zoi200503r13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173660","article-title":"D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: a meta-analysis.","volume":"12","author":"B\u00fcrkner","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"zoi200503r14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/YIC.0b013e32819f8480","article-title":"D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.","volume":"22","author":"Storch","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"issue":"8","key":"zoi200503r15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/jamapsychiatry.2016.1128","article-title":"Efficacy of augmentation of cognitive behavior therapy with weight-adjusted D-cycloserine vs placebo in pediatric obsessive-compulsive disorder: a randomized clinical trial.","volume":"73","author":"Storch","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"zoi200503r16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eurpsy.2016.06.011","article-title":"D-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder.","volume":"40","author":"de Leeuw","year":"2017","journal-title":"Eur Psychiatry"},{"issue":"7","key":"zoi200503r17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/jamapsychiatry.2015.0546","article-title":"D-cycloserine vs placebo as adjunct to cognitive behavioral therapy for obsessive-compulsive disorder and interaction with antidepressants: a randomized clinical trial.","volume":"72","author":"Andersson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"zoi200503r18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/da.2013.30.issue-8","article-title":"Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.","volume":"30","author":"Farrell","year":"2013","journal-title":"Depress Anxiety"},{"issue":"1","key":"zoi200503r19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12888-018-1887-4","article-title":"Successfully treating 90 patients with obsessive compulsive disorder in eight days: the Bergen 4-day treatment.","volume":"18","author":"Kvale","year":"2018","journal-title":"BMC Psychiatry"},{"key":"zoi200503r20","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3389\/fpsyg.2019.01069","article-title":"The Bergen 4-day treatment for obsessive-compulsive disorder: does it work in a new clinical setting?","volume":"10","author":"Launes","year":"2019","journal-title":"Front Psychol"},{"issue":"5","key":"zoi200503r21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1017\/S1352465817000091","article-title":"Concentrated ERP delivered in a group setting: a replication study.","volume":"45","author":"Havnen","year":"2017","journal-title":"Behav Cogn Psychother"},{"issue":"4","key":"zoi200503r22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jocrd.2014.08.002","article-title":"Concentrated ERP delivered in a group setting: an effectiveness study.","volume":"3","author":"Havnen","year":"2014","journal-title":"J Obsessive Compuls Relat Disord"},{"key":"zoi200503r23","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3389\/fpsyg.2019.02500","article-title":"A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment.","volume":"10","author":"Launes","year":"2019","journal-title":"Front Psychol"},{"issue":"2","key":"zoi200503r24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/16506073.2018.1478447","article-title":"The Bergen 4-day treatment for OCD: four years follow-up of concentrated ERP in a clinical mental health setting.","volume":"48","author":"Hansen","year":"2019","journal-title":"Cogn Behav Ther"},{"issue":"1","key":"zoi200503r25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/wps.v15.1","article-title":"Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder.","volume":"15","author":"Mataix-Cols","year":"2016","journal-title":"World Psychiatry"},{"issue":"3","key":"zoi200503r26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/da.2014.31.issue-3","article-title":"D-cycloserine for treating anxiety disorders: making good exposures better and bad exposures worse.","volume":"31","author":"Hofmann","year":"2014","journal-title":"Depress Anxiety"},{"key":"zoi200503r27","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"zoi200503r29","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive-Compulsive Scale: I. development, use, and reliability.","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"zoi200503r30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1037\/0022-006X.59.1.12","article-title":"Clinical significance: a statistical approach to defining meaningful change in psychotherapy research.","volume":"59","author":"Jacobson","year":"1991","journal-title":"J Consult Clin Psychol"},{"key":"zoi200503r31","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3389\/fpsyg.2017.01503","article-title":"The Dimensional Obsessive-Compulsive Scale: development and validation of a short form (DOCS-SF).","volume":"8","author":"Eilertsen","year":"2017","journal-title":"Front Psychol"},{"issue":"4","key":"zoi200503r32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1037\/1040-3590.14.4.485","article-title":"The Obsessive-Compulsive Inventory: development and validation of a short version.","volume":"14","author":"Foa","year":"2002","journal-title":"Psychol Assess"},{"issue":"10","key":"zoi200503r33","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7.","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"9","key":"zoi200503r34","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure.","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"3-4","key":"zoi200503r35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0149-7189(83)90010-1","article-title":"Assessment of patient satisfaction: development and refinement of a service evaluation questionnaire.","volume":"6","author":"Nguyen","year":"1983","journal-title":"Eval Program Plann"},{"issue":"12","key":"zoi200503r37","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.","volume":"63","author":"Norberg","year":"2008","journal-title":"Biol Psychiatry"},{"key":"zoi200503r39","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","article-title":"Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs.","volume":"4","author":"Lakens","year":"2013","journal-title":"Front Psychol"},{"key":"zoi200503r40","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2019.102149","article-title":"Changes in dosing and dose timing of D-cycloserine explain its apparent declining efficacy for augmenting exposure therapy for anxiety-related disorders: an individual participant-data meta-analysis.","volume":"68","author":"Rosenfield","year":"2019","journal-title":"J Anxiety Disord"},{"key":"zoi200503r28","volume-title":"Structured Clinical Interview for DSM-5\u2014Research Version","author":"First","year":"2015"},{"key":"zoi200503r38","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780195152968.001.0001","volume-title":"Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence","author":"Singer","year":"2003"},{"key":"zoi200503r36","unstructured":"Stewart-Brown? S, Janmohamed? K. Warwick-Edinburgh mental well-being scale. Updated September 12, 2018. Accessed July 16, 2020. https:\/\/warwick.ac.uk\/fac\/sci\/med\/research\/platform\/wemwbs\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2769240\/kvale_2020_oi_200503.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T04:30:01Z","timestamp":1597379401000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2769240"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.13249","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]}}}